PKNOX2 and persistent truncus arteriosus: Nevertheless, the in vivo study using the murine TAC model demonstrated a convincing therapeutic effect of enhancing PKNOX2 on alleviating myocardial fibrosis and cardiac dysfunction, indicating a novel potential antifibrotic target in heart failure remodelling.